Pathological treatment response has different prognostic implications for pancreatic cancer patients treated with neoadjuvant chemotherapy or chemoradiotherapy

Shimpei Maeda, Michael A. Mederos, Akhil Chawla, Alexandra M. Moore, Sami Shoucair, Lingdi Yin, Richard A. Burkhart, John L. Cameron, Joon Y. Park, Mark D. Girgis, Zev A. Wainberg, O. Joe Hines, Carlos Fernández‐del Castillo, Motaz Qadan, Keith D. Lillemoe, Cristina R. Ferrone, Jin He, Christopher L. Wolfgang, William R. Burns, Jun Yu, Timothy R. Donahue